​Welcome to MicroPhase Clinical Laboratory

MicroPhase Clinical Laboratory is an independent clinical microbiology laboratory serving Huntsville and the North Alabama area.  Our outpatient laboratory prides ourselves on creating professional, personal, and timely communication between the medical office and their patients.  Our goal is to provide healthcare professionals with a comprehensive report rapidly so they can ultimately enhance their patients care.

​
                     
​NEW! 
 Fluorescent Immunoassay (FIA)

SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The SARS Antigen FIA provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV.
Influenza A+B Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to detect influenza A and influenza B viral nucleoprotein antigens. Advance Result Technology (ART) delivers accurate, objective and automated results in as few as three minutes.
RSV Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to detect respiratory syncytial virus (RSV) nucleoprotein antigen directly from nasopharyngeal swab and nasopharyngeal aspirate/wash specimens from symptomatic patients. The high sensitivity of the RSV FIA offers confidence in rapid RSV testing. Advance Result Technology (ART) delivers accurate, objective and automated results in as few as three minutes.
Strep A+ Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to detect Group A Streptococcal antigens from throat swabs of symptomatic patients.
Lyme Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to provide rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi from finger-stick whole blood specimens from patients suspected of B. burgdorferi infection. Advance Result Technology (ART) delivers accurate, objective and automated results in as few as three minutes.

                           
                           
Molecular


Influenza A+B 
Influenza A+B Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
The assay consists of two major steps: (1) specimen preparation, and (2) amplification and detection of target sequences specific to influenza A and/or influenza B using isothermal Reverse Transcriptase — Helicase-Dependent Amplification (RT-HDA) in the presence of target-specific fluorescence probes.
Highly accurate molecular results in an actionable timeframe. Results you can trust for your high risk patients, on a
platform in just 45 minutes.
RSV + hMPV 
Enhance your respiratory testing with RSV and hMPV.
Human metapneumovirus is a common respiratory virus which often gets mistaken for respiratory syncytial virus when diagnosing based on
empirical evidence alone. Reduce onward transmission and avoid coinfection with RSV + hMPV.
Respiratory Viral Panel 
All the answers when you want them. Individual answers when you need them. RVP detects and differentiates the common respiratory viral strains of respiratory syncytial virus, human metapneumovirus, and
influenza A and B in as little as 45 minutes.
Bordetella Complete 
Enhance your respiratory testing options in your practice with BP and BPP.
Detect and differentiate Bordetella pertussis and Bordetella parapertussis in just 50 minutes
Strep Complete 
Group A and pyogenic Group C/G with no culture confirmation required.
Pyogenic group C/G strep is a significant cause of strep pharyngitis in teenagers and adults. These strains will go undetected when using a
rapid antigen test. Differentiate between A and the pyogenic C/G strains in just 30 minutes.


GBS 
Accurate results when it matters most.
Obtain accurate GBS results faster than traditional GBS testing methods and help prevent transmission of GBS from mother to newborn.


HSV 1+2/VZV 
Remove the uncertainty in your lesion diagnosis.
Detect and differentiate herpes simplex virus type 1, herpes simplex virus type 2, and varicella-zoster virus from any lesion in just 60 minutes.
Trichomonas 
Stop compromising. Start treating. The CDC recommends testing for trichomonas using highly sensitive Nucleic Acid Amplification Tests to avoid the underdiagnosis and undertreatment of trichomonas infections.
C. difficile 
Molecular testing with connectivity for easy results monitoring.
Change the way you monitor C. difficile results with Virena®. Virena provides an electronic patient de-identified data management system to
monitor results on a daily basis.

​